Mitochondrial long chain fatty acid oxidation, fatty acid translocase/ CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise

Journal of Physiology

Volumn 571, Issue 1, 2006, Pages 201-210

  Holloway, Graham P ^a   Bezaire, Veronic ^a   Heigenhauser, George J F ^b   Tandon, Narendra N ^c   Glatz, Jan F C ^d   Luiken, Joost J F P ^d   Bonen, Arend ^a   Spriet, Lawrence L ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CD36 ANTIGEN; CITRATE SYNTHASE; MITOCHONDRIAL PROTEIN; PALMITIC ACID; VERY LONG CHAIN FATTY ACID; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; GLUCOSE; GLYCEROL; LACTIC ACID; LONG CHAIN FATTY ACID; MALONYL COENZYME A; PALMITOYL COENZYME A;

ADULT; AEROBIC EXERCISE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLING; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME KINETICS; FATTY ACID OXIDATION; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; MALE; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE MITOCHONDRION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SKELETAL MUSCLE; WESTERN BLOTTING; CORRELATIONAL STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HUMAN TISSUE; IN VITRO STUDY; LACTATE BLOOD LEVEL; REST; YOUNG ADULT;

ADULT; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BLOTTING, WESTERN; CARNITINE O-PALMITOYLTRANSFERASE; CITRATE (SI)-SYNTHASE; EXERCISE; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; MALE; MALONYL COENZYME A; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OLEIC ACIDS; OXIDATION-REDUCTION; PALMITATES; SUCCINIMIDES; TIME FACTORS;

EID: 33645892283     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.102178     Document Type: Article

References (32)

1. Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E & Grimaldi PA (1993). Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268, 17665-17668.
2. Bergmeyer HU (1974). Methods in Enzymatic Analysis. Academic Press, New York.
3. Bergstrom J (1975). Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Laboratory Invest 35, 609-616.
4. Bezaire V, Bruce CR, Heigenhauser GJF, Tandon NN, Glatz JF, Luiken JJ, Bonen A & Spriet LL (2005). Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: Essential roles in fatty acid transport. Am J Physiol Endocrinol Metab (in press; DOI).
5. Bezaire V, Heigenhauser GJF & Spriet LL (2004). Regulation of CPT I activity in intermyofibrillar and subsarcolemmal mitochondria from human and rat skeletal muscle. Am J Physiol Endocrinol Metab 286, E85-E91.
6. Bonen A, Campbell S, Benton C, Chabowski A, Coort S, Han Z, Koonen D, Glatz J & Luiken J (2004). Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutrition Soc 63, 245-249.
7. Bonen A, Luiken JJ, Arumugam Y, Glatz JF & Tandon NN (2000). Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem 275, 14501-14508.
8. Bonen A, Parolin M, Steinberg G, Calles-escandon J, Heigenhauser G & Dyck D (2004). Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18, 1144-1146.
9. Campbell S, Tandon N, Woldegiorgis G, Luiken J, Glatz J & Bonen A (2004). A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J Biol Chem 279, 36235-36241.
10. Chien D, Dean D, Saha A, Flatt J & Ruderman N (2000). Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am J Physiol Endocrinal Metab 279, E259-E265.
11. Coort S, Luiken J, van der Vusse G, Bonen A & Glatz J (2004). Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. Biochem Soc Trans 32, 83-85.
12. Coort SL, Willems J, Coumans WA, van der Vusse GJ, Bonen A, Glatz JF & Luiken JJ (2002). Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake. Mol Cell Biochem 239, 213-219.
13. Dean D, Daugaard JR, Young ME, Saha A, Vavvas D, Asp S, Kiens B, Kim KH, Witters L, Richter EA & Ruderman N (2000). Exercise diminishes the activity of acetyl-CoA carboxylase in human muscle. Diabetes 49, 1295-1300.
14. Faye A, Borthwick K, Esnous C, Price N, Gobin S, Jackson V, Zammit V, Girard J & Prip-buus C (2005). Demonstration of N- and C-terminal domain intramolecular interactions in rat liver carnitine palmitoyltransferase 1 that determine its degree of malonyl-CoA sensitivity. Biochem J 387, 67-76.
15. Jimenez M, Yvon C, Lehr L, Leger B, Keller P, Russell A, Kuhne F, Flandin P, Giacobino JP & Muzzin P (2002). Expression of uncoupling protein-3 in subsarcolemmal and intermyofibrillar mitochondria of various mouse muscle types and its modulation by fasting. Eur J Biochem 269, 2878-2884.
16. Matsuno K, Diaz-Ricart M, Montgomery RR, Aster RG, Jamieson GA & Tandon NN (1996). Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol 92, 960-967.
17. McGarry JD & Brown NF (1997). The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244, 1-14.
18. McGarry JD, Mills SE, Long CS & Foster DW (1983). Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214, 21-28.
19. Napal L, Dai J, Treber M, Haro D, Marrero PF & Woldegiorgis G (2003). Single amino acid change (substitution of the conserved Glu-590 with alanine) in the C-terminal domain of rat liver carnitine palmitoyltransferase I increases its malonyl-CoA sensitivity close to that observed with the muscle isoform of the enzyme. J Biol Chem 278, 34084-34089.
20. O'Neill M, Watt MJ, Heigenhauser GJ & Spriet LL (2004). Effects of reduced free fatty acid availability on hormone-sensitive lipase activity in human skeletal muscle during aerobic exercise. J Appl Physiol 97, 1938-1945.
21. Odland LM, Heigenhauser GJ, Lopaschuk GD & Spriet LL (1996). Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am J Physiol 270, 541-544.
22. Odland LM, Howlett RA, Heigenhauser GJ, Hultman E & Spriet LL (1998). Skeletal muscle malonyl-CoA content at the onset of exercise at varying power outputs in humans. Am J Physiol 274, E1080-E1085.
23. Peronnet F & Massicotte D (1991). Table of nonprotein respiratory quotient: An update. Can J Sport Sci 16, 23-29.
24. Ramsay RR & Naismith JH (2003). A snapshot of carnitine acetyltransferase. Trends Inbiochem Sci 28, 343-346.
25. Roepstorff C, Halberg N, Hillig T, Saha AK, Ruderman NB, Wojtaszewski JF, Richter EA & Kiens B (2005). Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am J Physiol Endocrinalmetab 288, E133-E142.
26. Srere PA (1969). Citrate synthase. Methods Enzymol 8, 3-5.
27. Starritt EC, Howlett RA, Heigenhauser GJ & Spriet LL (2000). Sensitivity of CPT I to malonyl-CoA in trained and untrained human skeletal muscle. Am J Physiol Endocrinol Metab 278, E462-E462.
28. van Loon LJ (2004). Use of intramuscular triacylglycerol as a substrate source during exercise in humans. J Appl Physiol 97, 1170-1187.
29. Watt MJ, Heigenhauser GJ, O'Neill M & Spriet LL (2003). Hormone-sensitive lipase activity and fatty acyl-CoA content in human skeletal muscle during prolonged exercise. J Appl Physiol 95, 314-321.
30. Watt MJ, Holmes AG, Steinberg GR, Mesa JL, Kemp BE & Febbraio MA (2004). Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle. Am J Physiol Endocrinol Metab 287, E120-E127.
31. Winder WW, Arogyasami J, Elayan IM & Cartmill D (1990). Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol 259, E266-E271.
32. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S & Zhou B (1997). Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82, 219-225.